Skip to content
Peptigraph home

Enclomiphene for Men: Studies and Label Warnings

Studies of Enclomiphene that enrolled only men, what they measured, and what is still unproven.

Medical review pendingSERM (not a peptide)Updated
Strongest evidence
Human RCT
Studies enrolling only men
7
in our evidence file (PubMed search, 11 Oct 2026)
FDA status
Not approved

Studies that enrolled only men

Each row is a study whose participants were described as men only. Results from one sex are not evidence for the other. Studies of animals and cells are not included.

Enclomiphene studies that enrolled only men
StudyDesignPopulationDoseFirst outcome
BJU international 2016, PMID 26496621Human RCTOverweight men aged 18-60 with secondary hypogonadism (two parallel phase III studies, ZA-304 and ZA-305)two doses of enclomiphene citrate vs testosterone gel (AndroGel 1.62%)Total testosterone: Total testosterone rose from baseline at 16 weeks in all groups, including enclomiphene.
Fertility and sterility 2014, PMID 25044085Human RCTMen with secondary hypogonadism (phase II)Not statedTestosterone, LH, sperm: Enclomiphene raised morning testosterone, estradiol and LH similarly to topical gel; sperm counts conserved.
The journal of sexual medicine 2013, PMID 23530575Human RCTMen with secondary hypogonadism previously treated with topical testosterone (phase IIB, open-label)Not statedTotal testosterone at 6 months: At 6 months total testosterone was 545 (gel) and 525 (enclomiphene) pg/dL.
BJU international 2013, PMID 23875626Human RCTMen with secondary hypogonadism (phase II; 44 completed per protocol)6.25, 12.5 or 25 mgTotal testosterone at day 42: At 25 mg daily, day-42 testosterone averaged 604 ng/dL versus 500 ng for transdermal testosterone.
Translational andrology and urology 2024, PMID 39434750Human observationalMen at one academic centre switched from clomiphene to enclomiphene (retrospective)Not statedMedian testosterone change: Median testosterone increase was 166 with enclomiphene versus 98 ng/dL with clomiphene (P=0.20, not significant).
Archives of endocrinology and metabolism 2025, PMID 41066380Meta-analysisMen with functional hypogonadism; RCTs of clomiphene or enclomiphene vs placebo, T gel or hCGNot statedTotal testosterone vs placebo: SERMs (clomiphene or enclomiphene) raised total testosterone by a mean 273.76 ng/dL versus placebo, with high heterogeneity (I2 = 89%).
Andrology 2023, PMID 36604313Meta-analysisMen with obesity-related functional androgen deficiency, 7 studiesenclomiphene citrate 12.5-25 mg daily; clomiphene 12.5-50 mg dailyTestosterone with enclomiphene: Pooled testosterone rose by a mean 7.50 nmol/L with enclomiphene (and 11.56 nmol/L with clomiphene).

Peptides studied in men, compared

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Why this page covers men only

MedlinePlus lists low testosterone among the conditions that only affect men.[13]

Studies that enrolled only men

The two phase III trials enrolled overweight men aged 18-60 with secondary hypogonadism and compared two enclomiphene doses with testosterone gel.[1]

The phase II dose study enrolled forty-eight men with low total testosterone and tested three enclomiphene doses against transdermal testosterone.[4]

A proof-of-principle study of 12 men with secondary hypogonadism who had been on topical testosterone found testosterone and sperm counts rose with enclomiphene.[3]

A pooled analysis of obesity-related androgen deficiency covered 292 men given clomiphene or enclomiphene daily for 1.5-4 months.[7]

A retrospective review of 66 patients switched from clomiphene to enclomiphene and found lower estradiol change and fewer reported adverse effects.[5]

Safety findings in these men

The pooled obesity-related analysis registered no treatment-related unexpected findings regarding safety.[7]

The 66-patient review found decreased libido, reduced energy and mood changes significantly less frequent on enclomiphene than clomiphene.[5]

No data for women

Every cited enclomiphene study enrolled men (for example, men with secondary hypogonadism); none of these results can be applied to women.[2]

Other peptides people research for men

All peptides for men, compared

Common questions

Has Enclomiphene been studied in men?

7 studies we summarise enrolled only men. Results from one sex are not evidence for the other.

Is enclomiphene approved for men?

Not in the register lookup: Drugs@FDA returned no match on 2026-10-02.[14]

More on Enclomiphene

Sources

  1. 1Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.BJU international · 2016PMID 26496621Accessed 2 Oct 2026
  2. 2Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.Fertility and sterility · 2014PMID 25044085Accessed 2 Oct 2026
  3. 3Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel.The journal of sexual medicine · 2013PMID 23530575Accessed 2 Oct 2026
  4. 4Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics.BJU international · 2013PMID 23875626Accessed 2 Oct 2026
  5. 5Safety and efficacy of enclomiphene and clomiphene for hypogonadal men.Translational andrology and urology · 2024PMID 39434750Accessed 2 Oct 2026
  6. 6Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials.Archives of endocrinology and metabolism · 2025PMID 41066380Accessed 2 Oct 2026
  7. 7Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis.Andrology · 2023PMID 36604313Accessed 2 Oct 2026
  8. 8PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR "trans-clomiphene"[tiab] (98 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR meta-analysis[pt]) (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab]) AND humans[mh] (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR Androxal[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  13. 13Official web pageOfficial web page · web page
  14. 14Drugs@FDA (openFDA) search: active ingredient "enclomiphene"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026

Found an error? Report a correction.